NEOGENOMICS INC 4
4 · NEOGENOMICS INC · Filed May 2, 2017
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-04-28$7.52/sh+50,000$376,000→ 50,000 totalExercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (50,000 underlying)
Holdings
- 20,000
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (20,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 25,953
Common Stock
- 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying)
Footnotes (4)
- [F1]On March 5, 2014, Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- [F2]On May 4, 2015, Dr. Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F3]On April 20, 2016, Dr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On April 28, 2017, Dr. Brodie was granted 50,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.